HK39294A - Injectable compositions containing 25-cyclohexyl-avermectin B1 - Google Patents

Injectable compositions containing 25-cyclohexyl-avermectin B1 Download PDF

Info

Publication number
HK39294A
HK39294A HK39294A HK39294A HK39294A HK 39294 A HK39294 A HK 39294A HK 39294 A HK39294 A HK 39294A HK 39294 A HK39294 A HK 39294A HK 39294 A HK39294 A HK 39294A
Authority
HK
Hong Kong
Prior art keywords
avermectin
compound
cyclohexyl
sesame oil
ethyl oleate
Prior art date
Application number
HK39294A
Other languages
German (de)
English (en)
French (fr)
Inventor
Stephen Richard Dr. Wicks
Edward Mr. Davison
Original Assignee
Pfizer Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898908071A external-priority patent/GB8908071D0/en
Application filed by Pfizer Limited filed Critical Pfizer Limited
Publication of HK39294A publication Critical patent/HK39294A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
HK39294A 1989-04-11 1994-04-28 Injectable compositions containing 25-cyclohexyl-avermectin B1 HK39294A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898908071A GB8908071D0 (en) 1989-04-11 1989-04-11 Antiparasitic formulations
SG27894A SG27894G (en) 1989-04-11 1994-02-22 Injectable compositions containing 25-cyclohexyl-avermectin B1

Publications (1)

Publication Number Publication Date
HK39294A true HK39294A (en) 1994-05-06

Family

ID=26295191

Family Applications (1)

Application Number Title Priority Date Filing Date
HK39294A HK39294A (en) 1989-04-11 1994-04-28 Injectable compositions containing 25-cyclohexyl-avermectin B1

Country Status (16)

Country Link
EP (1) EP0393890B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPH0647548B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1035356C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AP (1) AP133A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU609660B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CY (1) CY1777A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK0393890T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EG (1) EG18956A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2052173T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI92015C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3005794T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HK (1) HK39294A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO175882C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
OA (1) OA09203A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RU (1) RU1836084C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SG (1) SG27894G (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19613972A1 (de) * 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
EP0928136B1 (en) * 1996-06-05 2003-10-22 Ashmont Holdings Limited Injectable compositions
DE19638045A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen
KR20000025762A (ko) * 1998-10-14 2000-05-06 유충식 이버멕틴류의 가용화 조성물
GB9827727D0 (en) 1998-12-16 1999-02-10 Pfizer Ltd Antiparasitic formulations
US20100022469A1 (en) * 2008-06-24 2010-01-28 Majid Razzak Anthelminthic formulations
US8551962B2 (en) * 2009-02-16 2013-10-08 Zoetis Llc High dosage doramectin formulation
MX2012004133A (es) * 2009-10-07 2012-05-08 Wyeth Llc Composiciones que comprenden adyuvante, macrolido y antigeno proteico y procedimientos de uso de las mismas.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8502511A (nl) * 1984-09-14 1986-04-01 Glaxo Group Ltd Chemische verbindingen en werkwijze ter bereiding daarvan.
ES8802229A1 (es) * 1985-04-30 1988-04-16 Glaxo Group Ltd Un procedimiento para preparar nuevos derivados lactonicos macrociclicos.
US4707470A (en) * 1985-05-17 1987-11-17 Smithkline Beckman Corporation Polyene antibiotic emulsion formulation
EP0285561A3 (de) * 1987-03-27 1989-10-25 Ciba-Geigy Ag Parasitizide und insektizide Milbemycin-Derivate
ES2045146T3 (es) * 1987-11-09 1994-01-16 Pfizer Avermectinas etiladas.

Also Published As

Publication number Publication date
EG18956A (en) 1994-04-30
JPH0647548B2 (ja) 1994-06-22
NO901637L (no) 1990-10-12
FI901816A0 (fi) 1990-04-10
CY1777A (en) 1995-10-20
CN1035356C (zh) 1997-07-09
CN1046282A (zh) 1990-10-24
EP0393890B1 (en) 1992-08-12
NO901637D0 (no) 1990-04-10
FI92015B (fi) 1994-06-15
RU1836084C (ru) 1993-08-23
OA09203A (fr) 1992-06-30
NO175882C (no) 1994-12-28
AU5311990A (en) 1990-11-08
AU609660B2 (en) 1991-05-02
DK0393890T3 (da) 1992-09-28
EP0393890A1 (en) 1990-10-24
AP133A (en) 1991-06-05
ES2052173T3 (es) 1994-07-01
GR3005794T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-06-07
FI92015C (fi) 1994-09-26
AP9000174A0 (en) 1990-04-30
SG27894G (en) 1995-03-17
NO175882B (no) 1994-09-19
JPH02290820A (ja) 1990-11-30

Similar Documents

Publication Publication Date Title
EP0535734B1 (en) Long acting injectable formulations containing hydrogenated castor oil
EP1136081B1 (en) Sustained-release compositions for the parenteral administration of macrolides
EP0413538A1 (en) Long active injectable formulations containing triacetin
EP0393890B1 (en) Injectable compositions containing 25-cyclohexyl-avermectin b1
US6001822A (en) Antiparasitic formulations
US6699847B2 (en) Antiparasitic formulation
CA2014157C (en) Antiparasitic formulation containing 25-cyclohexyl-avermectin b1
KR920006913B1 (ko) 구충제 제형
KR100315465B1 (ko) 수용성고분자와알코올을포함하는주사제용동물구충제조성물
MXPA01006175A (en) Doramectin formulations
BRPI0101090B1 (pt) Composition for parenteral administration understanding a macrolíde compound of the class of milbemicines

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090406